Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.303 SEK | -0.33% |
|
-5.02% | -65.57% |
14/06 | Biosergen AB Approves Board Changes | CI |
11/06 | Biosergen AB Receives the Final Permission Required to Test Lead Candidate BSG005 in Patients with Invasive Fungal Infection | CI |
Turnover - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
EBIT
Cash or Net Debt
- Stock Market
- Equities
- BIOSGN Stock
- Revisions Biosergen AB